The NPS has produced an informative update regarding Ferinject. Ferinject is ‘Ferric carboxymaltose (FCM) and is a parenteral iron preparation. FCM is an alternative iron preparation to consider in people aged ≥ 14 years with iron-deficiency anaemia ( IDA) who require rapid iron repletion. Ferinject allows larger single doses to be administered over a shorter infusion period compared with existing IV iron preparations.
The ability to deliver a high dose of iron within a short time frame may make FCM suitable for use in a primary care setting. However, FCM is unlikely to provide any advantage compared with existing IV agents for correcting IDA in patients with haemodialysis-dependent chronic kidney disease (CKD).
Closely monitor patients for signs of hypersensitivity during and for 30 minutes after the injection. FCM is for IV use only; do not administer as a subcutaneous or intramuscular injection. Read the enclosed article to learn more about this drug.